Functions of natural killer cells
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells are effector lymphocytes of the innate immune system that control several types of tumors and microbial infections by limiting their spread and subsequent tissue damage. Recent research highlights the fact that NK cells are also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, T cells and endothelial cells. NK cells can thus limit or exacerbate immune responses. Although NK cells might appear to be redundant in several conditions of immune challenge in humans, NK cell manipulation seems to hold promise in efforts to improve hematopoietic and solid organ transplantation, promote antitumor immunotherapy and control inflammatory and autoimmune disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, myofibroblasts that fail to enter senescence and continue to produce scar tissue are resistant to NK activity and perpetuate fibrosis even after the inflammatory stimulus has reduced.84,85”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [84]
Citations
Cites
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975 · cited 1×
“In humans, NK cells can be divided into CD56 dim and CD56 bright NK cell subsets, which differ in their homing propertie”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 1×
“NK cells were later recognized as a separate lymphocyte lineage, with both cytotoxicity and cytokine-producing effector function”
BackgroundLanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 1×
“Activating NK cell receptors detect the presence of ligands on cells in 'distress', such as the stress-induced self ligands recognized by NKG2D (human ULBP and MIC molecules, as well as mouse RAE1, H60 and MULT1 molecules”
BackgroundSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161 · cited 1×
“As a consequence, NK cells have been described as able to recognize 'missing self' on hematopoietic cell”
BackgroundNATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113 · cited 1×
“, whereas chemokines such as CCL3 (MIP-1α), CXCL10 (IP-10) and CXCL9 (MIG) coordinately regulate NK cell traffickin”
BackgroundMiller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903 · cited 1×
“, and NK cell–mediated therapy after hematopoietic cell transplantation seems saf”
BackgroundDecidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681 · cited 1×
“uNK represent a very distinct subset of NK cells that secrete proangiogenic factors such as vascular endothelial growth factor (VEGF), placental growth factor (PLGF) and NKG5 (ref”
BackgroundInduced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340 · cited 1×
“This education process requires the recognition of self–MHC class I molecules by cognate inhibitory receptors, such as Ly49 molecules in mice and KIRs in human”
BackgroundDirect Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
Research works printed but not linked: 1
- Stewart, C.A. & Vivier, E. Strategies of NK cell recognition and their roles in tumor immunosurveillance. in How the Immune System Recognizes Self and Nonself: Immunoreceptors and Their Signaling (ed. Kitamura, D.) 37–81 (Springer, Tokyo, 2007).
Cited by
Items 801–900 of 1,008
Natural Killer Cells and the Immune Response in Solid Organ Transplantation
van der Touw, W., & Bromberg, J. S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03086.x · Cited by 66
“These receptors and their roles in NK cell surveillance and cytolysis have been well studied and are closely associated with the identity of NK cells (2).”
BackgroundDemethylating treatment suppresses natural killer cell cytolytic activity
Gao, X., Lin, J., Wang, L.-L., & Yu, L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.033 · Cited by 60
Leptin modulates dose‐dependently the metabolic and cytolytic activities of NK‐92 cells
Lamas, B., Gonçalves-Mendes, N., Nachat, R., Rossary, A., Caldefie‐Chezet, F., Vasson, M., & Farges, M. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24273 · Cited by 67
“NK cells are a subgroup of lymphocytes that play an essential role in the cellular based immune defense of virus infected and transformed cells (Vivier et al., 2008).”
BackgroundInfluentialTrueba, A. F., & Ritz, T. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.09.012 · Cited by 73
“NK cells also protect against viral infections that can exacerbate asthma and can also reduce inflammation (Vivier et al., 2008).”
BackgroundWagner, J. A., Berrien-Elliott, M. M., Rosario, M., Leong, J. W., Jewell, B. A., Schappe, T., Abdel-Latif, S., & Fehniger, T. A. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.11.018 · Cited by 64
Li, L., Li, W., Wang, C., Xu, Y., Wang, Y., Niu, C. S., Zhang, X., Li, M., Tian, H., Cheng, Y., et al. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.09.009 · Cited by 60
Wang, H., Zhang, Y., Wu, X., Wang, Y., Cui, H., Li, X., Zhang, J., Tun, N., Peng, Y., & Yu, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00293 · Cited by 66
“Rapid IFN-γ production plays a critical role in defending against infectious pathogens by promoting both innate and adaptive immune responses (1, 3).”
BackgroundVaricella zoster virus productively infects human natural killer cells and manipulates phenotype
Campbell, T. M., McSharry, B. P., Steain, M. C., Ashhurst, T. M., Slobedman, B., & Abendroth, A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006999 · Cited by 63
Gao, F., Ye, Y., Gao, Y., Huang, H., & Zhao, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02022 · Cited by 63
“The higher level of IFN-γ secretion from theNK cells might trigger Th1 immune responses, antigen presentation cell activation, and macrophage killing (7, 8), leading to lower infection rate.”
BackgroundRussick, J., Torset, C., Hemery, E., & Cremer, I. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101407 · Cited by 64
The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells
Narni-Mancinelli, É., Vivier, É., & Kerdiles, Y. M. (2011) · International Immunology · doi:10.1093/intimm/dxr035 · Cited by 77
Huang, Y., Wang, Y., Li, Y., Guo, K., & He, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0944-2 · Cited by 59
“Materials revealed that NK cells possessed extensive anti-tumor effects, not only showed excellent cytotoxicity against various tumor cell lines such as leukemia, lymphoma, myeloma, melanoma, prostatic carcinoma, and breast cancer cell lines in vitro but also displayed effective tumor inhibitory activity in xenografte…”
ITCH as a potential therapeutic target in human cancers
Yin, Q., Wyatt, C. J., Han, T., Smalley, K. S. M., & Wan, L. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.003 · Cited by 63
Coffee and its effects on the immune system
Açıkalın, B., & Şanlıer, N. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.06.023 · Cited by 62
Anti-inflammatory potential of platinum nanozymes: mechanisms and perspectives
Bardi, G., Boselli, L., & Pompa, P. P. (2023) · Nanoscale · doi:10.1039/d3nr03016d · Cited by 62
Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy
Oirdi, M. E. (2024) · Pharmaceuticals · doi:10.3390/ph17060692 · Cited by 69
“Below are the results of multiple phytochemical screenings and current clinical trials on polyphenols and polyphenol-based therapies for various disorders.”
BackgroundImmune Regulation of Human Herpesviruses and Its Implications for Human Transplantation
Smith, C., & Khanna, R. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12005 · Cited by 67
“NK cells express a complex array of stimulatory and inhibitory receptors that function to promote or suppress activation of the NK cell in response to ligands expressed on the surface of target cells (13).”
BackgroundRole of NK Cells in Influenza Infection
Schultz‐Cherry, S. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_403 · Cited by 59
HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells
Fausther‐Bovendo, H., Sol‐Foulon, N., Candotti, D., Agut, H., Schwartz, O., Debré, P., & Vieillard, V. (2009) · AIDS · doi:10.1097/qad.0b013e32832cb26b · Cited by 59
“It is the integration of signals that are perceived by these NK cell surface receptors that determines NK cell activity [25,26].”
BackgroundInterferon-alpha Subtype 11 Activates NK Cells and Enables Control of Retroviral Infection
Sutter, K., Joedicke, J. J., Meryk, A., Trilling, M., Francois, S., Duppach, J., Kraft, A. R. M., Lang, K. S., & Dittmer, U. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002868 · Cited by 65
“Therefore, the antiviral activity of IFN-a11 in a murine CMV (MCMV) infection was analyzed.”
BackgroundInfluentialLogan, R. W., Wynne, O., Levitt, D., Price, D., & Sarkar, D. K. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0092 · Cited by 60
Acupuncture May Stimulate Anticancer Immunity via Activation of Natural Killer Cells
Johnston, M. F., Ortiz Sánchez, E., Vujanovic, N. L., & Li, W. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nep236 · Cited by 59
“NK cells arise from multipotent hematopoietic stem cells (HSCs) that differentiate through a series of defined phenotypic stages.”
BackgroundOpportunities and limitations of natural killer cells as adoptive therapy for malignant disease
Davies, J. O. J., Stringaris, K., Barrett, A. J., & Rezvani, K. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.03.009 · Cited by 65
“In addition, NK cells secrete cytokines, such as interferon-g and tumor necrosis factor-a, and are involved in regulating the function of other lymphocytes, macrophages, dendritic cells and endothelial cells [10].”
BackgroundZhao, J., Li, Y., Jin, L., Zhang, S., Fan, R., Sun, Y., Zhou, C., Shang, Q., Li, W., Zhang, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049135 · Cited by 67
“Type I interferon (IFN), interleukin (IL)-12, IL-15 and IL-18 are potent activators of NK cell function [16].”
BackgroundThe mechanisms of acute transplant rejection revisited
Ponticelli, C. E. (2011) · Journal of Nephrology · doi:10.5301/jn.5000048 · Cited by 67
“Inhibitory receptors include the MHC class I receptors which mediate NK cell functions so that they selectively kill target cells (33).”
BackgroundTNFα Augments Cytokine-Induced NK Cell IFNγ Production through TNFR2
Almishri, W., Santodomingo-Garzón, T., Le, T. S., Stack, D., Mody, C. H., & Swain, M. G. (2016) · Journal of Innate Immunity · doi:10.1159/000448077 · Cited by 74
Quatrini, L., Wieduwild, É., Guia, S., Bernat, C., Glaichenhaus, N., Vivier, É., & Ugolini, S. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20171048 · Cited by 61
“Group 1 ILCs comprise conventional natural killer (NK) cells, which are present in many organs, including the spleen, and circulate between the blood and tissues (Vivier et al., 2008).”
BackgroundSelf-citationMicroRNA meta-signature of oral cancer: evidence from a meta-analysis
Zeljić, K., Jovanović, I. B., Jovanović, J., Magić, Z., Stanković, A., & Šupić, G. (2018) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2018.1439551 · Cited by 60
“In vitro studies on human and other mammal cells, as well as in vivo studies in rodents, have suggested that NK cells target tumor cells (46).”
BackgroundNatural killer cells induce neutrophil extracellular trap formation in venous thrombosis
Bertin, F., Rys, R. N., Mathieu, C., Laurance, S., Lemarié, C. A., & Blostein, M. D. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14339 · Cited by 59
Cifaldi, L., Doria, M., Cotugno, N., Zicari, S., Cancrini, C., Palma, P., & Rossi, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153715 · Cited by 69
Raková, J., Truxová, I., Holíček, P., Šálek, C., Hensler, M., Kašíková, L., Pasulka, J., Holubová, M., Kovář, M., Lysák, D., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1889822 · Cited by 67
S-Nitrosylation in Tumor Microenvironment
Sharma, V., Fernando, V., Letson, J., Walia, Y., Zheng, X., Fackelman, D., & Furuta, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094600 · Cited by 65
“Furthermore, activated NK cells regulate the activation and maturation of T cells, dendritic cells, and macrophages, which subsequently leads to an improved anti-tumor response [185].”
BackgroundDopamine, a co-regulatory component, bridges the central nervous system and the immune system
Li, M., Zhou, L., Sun, X., Yang, Y., Zhang, C., Wang, T., & Fu, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112458 · Cited by 65
Immunological nanomaterials to combat cancer metastasis
Pan, Y., Cheng, J., Zhu, Y., Zhang, J., Fan, W., & Chen, X. S. (2024) · Chemical Society Reviews · doi:10.1039/d2cs00968d · Cited by 61
Engineered natural killer cells for cancer therapy
Biederstädt, A., & Rezvani, K. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.09.013 · Cited by 69
IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
Laroni, A., Gandhi, R., Beynon, V., & Weiner, H. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026173 · Cited by 61
“Functional effects of IL-27 on CD56 and CD56 NK cell subsets Cytotoxicity is an important function of CD56 NK cells [22].”
BackgroundSanvito, L., Makowska, A. M., Gregson, N. A., Nemni, R., & Hughes, R. A. (2009) · Autoimmunity · doi:10.1080/08916930903140907 · Cited by 58
Lunemann, S., Malone, D. F. G., Grabowski, J., Port, K., Béziat, V., Bremer, B., Malmberg, K., Manns, M. P., Sandberg, J. K., Cornberg, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-306767 · Cited by 60
Sullivan, R. P., Fogel, L. A., Leong, J. W., Schneider, S. E., Wong, R., Romee, R., Thai, T.-H., Sexl, V., Matkovich, S. J., Dorn, G. W., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301950 · Cited by 50
“Upon cytokine receptor activation, NK cells acquire enhanced functional competence and also produce NK cell–derived cytokines/ chemokines, including IFN-g, GM-CSF, TNF-a, and MIP1-a (2).”
BackgroundGenome-wide analyses and functional profiling of human NK cell lines
Gunesch, J. T., Angelo, L. S., Mahapatra, S., Deering, R. P., Kowalko, J. E., Abou‐Sleiman, P. M., Tobias, J. W., Monaco-Shawver, L., Orange, J. S., & Mace, E. M. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.07.015 · Cited by 64
“NK cells also secrete cytokines and have been shown to produce co-stimulatory signals for activation of other immune cell types [3].”
BackgroundNeuroendocrine regulation of innate lymphoid cells
Quatrini, L., Vivier, É., & Ugolini, S. (2018) · Immunological Reviews · doi:10.1111/imr.12707 · Cited by 63
Self-citationIn vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation
Lee, Y., Shin, H.-W., & Kim, J. (2020) · Journal of Innate Immunity · doi:10.1159/000510315 · Cited by 62
Immunomodulation of NK Cells by Ionizing Radiation
Chen, J., Liu, X., Zeng, Z., Li, J., Luo, Y. M., Sun, W., Gong, Y. Q., Zhang, J., Wu, Q., & Xie, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00874 · Cited by 65
“NK cells can directly eliminate tumor cells through multiple ways: first, NK cells release cytotoxic granules containing perforin and granzymes, leading to cell lysis (2, 17).”
BackgroundThe Effects of Forest Therapy on Immune Function
Chae, Y., Lee, S., Jo, Y.-M., Kang, S., Park, S., & Kang, H. Y. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168440 · Cited by 74
“NK cells are capable of attacking and killing virus-infected cells or tumor cells and play an important role in the human endocrine and immune systems [37].”
BackgroundT-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells
Kiekens, L., Loocke, W. V., Taveirne, S., Wahlen, S., Persyn, E., Ammel, E. V., Vos, Z. D., Matthys, P., Nieuwerburgh, F. V., Taghon, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732511 · Cited by 66
“NK cells are potent producers of pro-inflammatory cytokines, including IFN-g (73).”
BackgroundPaired single-cell multi-omics data integration with Mowgli
Huizing, G.-J., Deutschmann, I. M., Peyré, G., & Cantini, L. (2023) · Nature Communications · doi:10.1038/s41467-023-43019-2 · Cited by 68
“Finally, in CD56 dim NK cells (factor 2),Mowgli detects at top genes: NCAM1 (aka CD56 ), the go-to marker for NK cells 68 ; KLRF1 and KLRD1 , genes of the KLR family of receptors controlling NK cell activity 69 ; GZMB , involved in NK-cell mediated cytotoxicity 70 ; SLAMF7 , mediating NK cell…”
Halder, R. C., Almasi, A., Sagong, B., Leung, J. C., Jewett, A., & Fiala, M. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00129 · Cited by 61
Zhang, Q., Sun, H., Zhang, K., Jia, Q., Bu, Y., Wang, M., Chai, Z., Zhang, Q., Wang, W., Kong, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055945 · Cited by 59
“NK cells, a major component of the innate immune system, can limit the growth and dissemination of several types of tumors [15].”
BackgroundAlveolar macrophage proteinase/antiproteinase expression in lung function and emphysema
Ishii, T., Abboud, R. T., Wallace, A. M. R., English, J. C., Coxson, H. O., Finley, R. J., Shumansky, K., Paré, P. D., & SANDFORD, A. J. (2013) · European Respiratory Journal · doi:10.1183/09031936.00174612 · Cited by 63
“is essential for natural killer T cell development [44], and natural killer cells, which have an essential role in immunity against viral infection [45], are decreased in the peripheral blood in”
BackgroundDendritic cell vaccination in acute myeloid leukemia
Anguille, S., Willemen, Y., Lion, E., Smits, E., & Berneman, Z. N. (2012) · Cytotherapy · doi:10.3109/14653249.2012.693744 · Cited by 64
Ebbo, M., Audonnet, S., Grados, A., Benarous, L., Mahévas, M., Godeau, B., Viallard, J., Pipéroglou, C., Cognet, C., Farnarier, C., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.11.005 · Cited by 57
Vashist, N., Trittel, S., Ebensen, T., Chambers, B. J., Guzmán, C. A., & Riese, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00505 · Cited by 60
Tremblay-McLean, A., Coenraads, S., Kiani, Z., Dupuy, F. P., & Bernard, N. F. (2019) · BMC Immunology · doi:10.1186/s12865-018-0272-x · Cited by 67
Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response
Châari, A., Bendriss, G., Zakaria, D., & McVeigh, C. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00476 · Cited by 65
Harker, J. A., Godlee, A., Wahlsten, J. L., Lee, D. C. P., Thorne, L., Sawant, D., Tregoning, J. S., Caspi, R. R., Bukreyev, A. A., Collins, P. L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02014-09 · Cited by 57
“For instance, NK cells have been shown to kill immature dendritic cells, activated CD4 T cells, and hyperactivated macrophages, the increased presence of all of which could increase CD8 T-cell numbers (29).”
BackgroundRoberti, M. P., Rocca, Y., Amat, M., Pampena, M. B., Loza, J., Coló, F. A., Fabiano, V. Y., Loza, C. M., Arriaga, J. M., Bianchini, M., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2287-y · Cited by 58
“NK cells are effector lymphocytes of the innate immune system [12] and the role in preventing and controlling BC tumor growth and metastasis in murine models has been documented [13] and there are therapeutic approaches which propose to use them for BC treatment [14, 15].”
BackgroundMerkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 71
The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment
Guo, Y., Xie, Y., & Luo, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.851004 · Cited by 64
“Firstly, NK cells directly release cytotoxic particles such as perforin and granzyme through exocytosis and activate the caspase pathway to induce target cell apoptosis (109).”
BackgroundBreznik, B., Ko, M.-W., Tse, C., Chen, P.-C., Senjor, E., Majc, B., Habič, A., Angelillis, N. A., Novak, M., Župunski, V., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03402-z · Cited by 66
Buechele, C., Baessler, T., Wirths, S., Schmohl, J. U., Schmiedel, B. J., & Salih, H. R. (2011) · Leukemia · doi:10.1038/leu.2011.313 · Cited by 57
Spreu, J., Kuttruff, S., Stejfova, V., Dennehy, K. M., Schittek, B., & Steinle, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913108107 · Cited by 63
“N killer (NK) cells express a diverse array of activating and inhibitory receptors regulating NK activity depending on their respective environmental “niche” (1, 2).”
BackgroundMicroRNA regulation of natural killer cells
Sullivan, R. P., Leong, J. W., & Fehniger, T. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00044 · Cited by 59
“The regulation of its production is complex and involves the integration of various signaling pathways (Vivier et al., 2008) and multiple layers of regulation (Young, 1996).”
BackgroundLima, M., Leander, M., Santos, M., Santos, A. H., Lau, C., Queirós, M. L., Gonçalves, M. M. D. S. L. B., Fonseca, S., Moura, J., Teixeira, M. D. A., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/839684 · Cited by 61
Kelly, M. N., Zheng, M., Ruan, S., Kolls, J. K., D’Souza, A., & Shellito, J. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200861 · Cited by 63
“system and are important effectors in host defense against pathogens and tumors (1).”
BackgroundNatural killer cells in hepatitis C: Current progress
Yoon, J. C., Yang, C. M., Song, Y., & Lee, J. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i4.1449 · Cited by 67
Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma
Abdelrahman, M. M., Fawzy, I. O., Bassiouni, A. A., Gomaa, A. I., Esmat, G., Waked, I. A., & Abdelaziz, A. I. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.04.020 · Cited by 56
An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
Koerner, S., Andre, M. C., Leibold, J., Kousis, P. C., Kübler, A., Pal, M., Haen, S. P., Bühring, H.-J., Grosse-Hovest, L., Jung, G., et al. (2016) · Leukemia · doi:10.1038/leu.2016.194 · Cited by 56
Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases
Parisi, L., Bassani, B., Tremolati, M., Gini, E., Farronato, G., & Bruno, A. (2017) · Journal of Immunology Research · doi:10.1155/2017/4218254 · Cited by 60
“Upon activation, CD56brightCD16− NK cells release IFN-γ and TNF-α, and they kill target cells more efficiently [20].”
BackgroundGondois‐Rey, F., Chéret, A., Granjeaud, S., Mallet, F., Bidaut, G., Lécuroux, C., Ploquin, M. J.-Y., Müller-Trutwin, M. C., Rouzioux, C., Avettand-Fènoël, V., et al. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.22 · Cited by 58
Extracellular vesicles: important collaborators in cancer progression
Sato, S., & Weaver, A. M. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170080 · Cited by 60
Cabanas, H., Muraki, K., Eaton-Fitch, N., Balinas, C., Staines, D., & Marshall‐Gradisnik, S. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0046-1 · Cited by 61
“NK cells are effector lymphocytes of the innate immune system that eliminate pathogens and tumour cells, in addition to immune cell activation and cytokine production (Vivier et al., 2008).”
Jun, E., Song, A. Y., Choi, J., Lee, H. H., Kim, M., Ko, D., Kang, H. J., Kim, S. W., Bryceson, Y. T., Kim, S. C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01354 · Cited by 62
“Natural killer (NK) cells are a subset of innate lymphoid cells that constitute a first line of defense against cancer development and metastasis (10, 11), patrolling a variety of tissues and comprising about 5–15% of total peripheral blood mononuclear cells (PBMCs) (12, 13).”
BackgroundChallenges in assessing solid tumor responses to immunotherapy
Chai, L. F., Prince, E. A., Pillarisetty, V. G., & Katz, S. C. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-019-0155-1 · Cited by 58
Péterfalvi, Á., Meggyes, M., Makszin, L., Farkas, N., Mikó, É., Miseta, A., & Szereday, L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18042067 · Cited by 66
“CD56dim NK cells bear low-density expression of CD56, whereas CD56bright NK cells express CD56 at a high density [46,54].”
BackgroundGong, W., Xiao, W., Hu, M., Weng, X., Li, Q., Pan, X., & Ming-chun, J. (2010) · Tissue Antigens · doi:10.1111/j.1399-0039.2010.01535.x · Cited by 61
NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells
Bi, J., Cui, L., Yu, G., Yang, X., Chen, Y., & Wan, X. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601830 · Cited by 56
“NK cells are robust IFN-g producers upon activation (4).”
BackgroundAging and Options to Halt Declining Immunity to Virus Infections
Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.681449 · Cited by 61
Ghasemzadeh, M., Ghasemzadeh, A., & Hosseini, E. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.09.004 · Cited by 63
“TCR chains are not rearranged in these cells [10].”
Ren, X., Peng, M., Peng, X., Yao, W., Galbo, P. M., Corrigan, D. T., Wang, H., Su, Y., Dong, X., Sun, Q., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci163620 · Cited by 66
“Natural killer (NK) cells are also crucial effector cells in immunosurveillance against infected and transformed cells (5).”
Cuitavi, J., Torres-Pérez, J. V., Lorente, J. D., Campos‐Jurado, Y., Andrés‐Herrera, P., Polache, A., Agustín‐Pavón, C., & Hipólito, L. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.105011 · Cited by 57
Wang, Q., Yu, M., & Zhang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440830 · Cited by 68
Brussel, I. V., Berneman, Z. N., & Cools, N. (2012) · Mediators of Inflammation · doi:10.1155/2012/690643 · Cited by 65
“However, since the same observation was also made for IL-3-stimulated pDC, such data could also be taken as an argument in favour of a similar relationship between BDCA-3+ DCs and pDCs [27].”
ResultInfluentialLee, S.-J., Cho, Y., Kim, T., Park, S., Park, D.-J., Jin, H., Lee, S., Kee, S., Kim, N., Yoo, D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34514 · Cited by 57
HIV controllers: A multifactorial phenotype of spontaneous viral suppression
Thèze, J., Chakrabarti, L. A., Vingert, B., Porichis, F., & Kaufmann, D. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.07.007 · Cited by 72
Sakai, Y., Tanaka, Y., Yanagihara, T., Watanabe, M., Duan, X., Terasawa, M., Nishikimi, A., Sanematsu, F., & Fukui, Y. (2013) · Blood · doi:10.1182/blood-2012-12-475897 · Cited by 55
“On the other hand, Ly49D triggers the killing of Chinese hamster ovary (CHO) cells by recognizing hamster MHC class I molecules,(5) and FcgRIIIa is involved in antibody-dependent cell-mediated cytotoxicity (ADCC).(1,2) Because these receptors lack cytoplasmic signaling elements, the delivery of activating signal is me…”
BackgroundInfluentialIs Infant Immunity Actively Suppressed or Immature?
Gervassi, A. L., & Horton, H. (2014) · Virology Research and Treatment · doi:10.4137/vrt.s12248 · Cited by 62
Expression and regulation of complement receptors by human natural killer cells
Min, X., Liu, C., Wei, Y., Wang, N., Yuan, G., Liu, D., Li, Z., Zhou, W., & Li, K. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.03.018 · Cited by 59
Bae, D. S., & Lee, J. K. (2014) · Blood Research · doi:10.5045/br.2014.49.3.154 · Cited by 56
“Although many kinds of autologous and allogenic NK cells have been applied in cancer therapy [1], clinical application has been somewhat limited because it is difficult to prepare a sufficient number of NK cells.”
BackgroundInterstitial laser thermotherapy (ILT) of breast cancer
Haraldsdóttir, K. H., Ivarsson, K. M., Götberg, S., Ingvar, C., Stenram, U., & Tranberg, K. ‐. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.01.008 · Cited by 57
NK cell-based cancer immunotherapy: from basic biology to clinical application
Li, Y., Yin, J., Li, T., Huang, S., Yan, H., Leavenworth, J. W., & Wang, X. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4970-9 · Cited by 60
Rudak, P. T., Choi, J., & Haeryfar, S. M. M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0118-023r · Cited by 64
Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy
Alfarra, H., Weir, J. A., Grieve, S., & Reiman, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575609 · Cited by 62
“They are the first responders against malignant and infected cells and are functionally classified by their innate capacity to eliminate cells without prior sensitization or recognition of presented antigens (16, 17).”
BackgroundInfluentialVeluchamy, J. P., Lopez-Lastra, S., Spanholtz, J., Bohme, F., Kok, N., Heideman, D. A. M., Verheul, H. M. W., Di Santo, J. P., de Gruijl, T. D., & van der Vliet, H. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00087 · Cited by 54
“The majority of NK cells are CD56dimCD16+ and play an active role in NK cell cytotoxicity and are capable of performing ADCC upon IgG1 engagement via CD16, whereas CD56brightCD16− NK cells are mainly immune regulatory in function, secreting cytokines, and are less cytotoxic than CD56dim cells (12).”
Helfrich, I., & Singer, B. B. (2019) · Cancers · doi:10.3390/cancers11030356 · Cited by 59
“Several studies have shown that soluble NKG2D-ligands derived from cancer cells by alternative splicing [19], proteolytic shedding [20–23], or exosome secretion [24] can impair NKG2D-mediated cytotoxicity by negatively regulating NKG2D surface expression.”
BackgroundFunctional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
Ruetsch-Chelli, C., Brglez, V., Crémoni, M., Zorzi, K., Fernandez, C., Boyer‐Suavet, S., Benzaken, S., Demonchy, É., Risso, K., Courjon, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.603961 · Cited by 61
“Days after first signs of COVID-19 11 (7; 17) NA 15 (10; 24) 9 (5; 13) 9 (5; 12) 0.”
Chai, X., Gu, Y., Lv, L., Chen, C., Feng, F., Cao, Y. W., Liu, Y., Zhu, Z., Hong, Z., Chai, Y., et al. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.05.006 · Cited by 54
“A variety of inhibitory and activating receptors can be expressed by NK cells, and the balance between these two receptors regulates the activation of NK cells [2].”
BackgroundNew insights into immunomodulatory properties of lactic acid bacteria fermented herbal medicines
Zhu, H., Guo, L., Yu, D., & Du, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1073922 · Cited by 60
CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
Włodarczyk, M., & Pyrzyńska, B. (2022) · Cancers · doi:10.3390/cancers15010117 · Cited by 57
“The short lifespan of NK cells (typically about two weeks [65]) guarantees the safety of CAR-NK therapy.”
BackgroundRacacho, K. J., Shiau, Y., Villa, R., Mahri, S., Tang, M., Lin, T., & Li, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1621812 · Cited by 72
Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies
Shifon, S., Викторовна, Т. Т., Veretel’nikova, T. V., Пасман, Н. М., & Chernykh, E. R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1727183 · Cited by 65
Metadata
- Authors
- Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Immunology
- Published
- 2008-04-18
- Volume
- 9
- Issue
- 5
- Pages
- 503-510
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2073300038
- Cited by
- 3,943
- References
- 109
- Citations by year
- 2026: 195 · 2025: 269 · 2024: 299 · 2023: 292 · 2022: 302 · 2021: 332 · 2020: 260 · 2019: 271 · 2018: 224 · 2017: 247 · 2016: 202 · 2015: 195 · 2014: 159 · 2013: 156 · 2012: 141
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- European Commission
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Ministère de l'Enseignement Supérieur et de la Recherche
- Centre National de la Recherche Scientifique
- Institut Universitaire de France
- Institut National Du Cancer
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, tumor control, microbial infection, regulatory function, dendritic cells, macrophages, T cells, endothelial cells, immune regulation, hematopoietic stem cell transplantation, solid organ transplantation, cancer immunotherapy, inflammation, autoimmune disease
- MeSH terms
- Animals, Autoimmune Diseases, Dendritic Cells, Host vs Graft Reaction, Humans, Immune Tolerance, Inflammation, Killer Cells, Natural, Macrophages, Neoplasms, T-Lymphocytes, Virus Diseases, Immunotherapy, Adoptive, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.